US Stock MarketDetailed Quotes
XGN Exagen
- 3.140
- +0.310+10.95%
Close Aug 16 16:00 ET
- 3.200
- +0.060+1.91%
Post 20:02 ET
54.59MMarket Cap-3237P/E (TTM)
3.210High2.600Low143.39KVolume2.760Open2.830Pre Close431.06KTurnover2.04%Turnover RatioLossP/E (Static)17.39MShares3.71052wk High3.11P/B22.07MFloat Cap1.30052wk Low--Dividend TTM7.03MShs Float29.858Historical High--Div YieldTTM21.55%Amplitude1.300Historical Low3.006Avg Price1Lot Size
About Exagen Company
Exagen, Inc. is a commercial-stage diagnostics company, which engages in transforming the care continuum for patients suffering from debilitating and chronic autoimmune diseases by enabling timely differential diagnosis and optimizing therapeutic intervention. It operates under the Avise brand. The company was founded by Waneta C. Tuttle and Cole Harris in 2002 and is headquartered in Vista, CA.
Company Profile
SymbolXGN
Company NameExagen
Listing DateSep 19, 2019
Issue Price14.00
Founded2002
CEOMr. John Aballi
MarketNASDAQ
Employees179
Fiscal Year Ends12-31
Address1261 Liberty Way,Suite C
CityVista
ProvinceCalifornia
CountryUnited States of America
Zip Code92081
Phone1-760-560-1501
Websitehttp://www.exagen.com
Company Executives
- Name
- Position
- Salary
- John Aballi
- Director, President, Interim Chief Financial Officer and Chief Executive Officer
- 931.95K
- Dr. Tina S. Nova, PhD
- Executive Chairman of the Board
- 132.81K
- Ana Hooker
- Independent Director
- 84.20K
- Paul Kim
- Independent Director
- 52.56K
- Frank Stokes
- Independent Director
- 82.70K
- Bruce C. Robertson, PhD
- Independent Director
- 33.75K
- Dr. Scott D. Kahn,PhD
- Independent Director
- --
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
% Chg